Vascular Imaging with Mvivo Au Micro-CT Contrast Agent

An independant study from Dr. Michael Lamba’s research group at the University of Cincinnati has found that Mvivo™ Au provides a stronger micro-CT contrast enhancement signal than commercially available ExiTron™ nano 12000.

MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).